| Autor: |
Criscuolo, Marianna, Broccoli, Alessandro, Galli, Eugenio, Piciocchi, Alfonso, Maraglino, Alessio, Anastasia, Antonella, Annibali, Ombretta, Cantonetti, Maria, De Luca, Maria Lucia, Fianchi, Luana, Frustaci, Annamaria, Galli, Elettra, Guarnera, Luca, Kovalchuk, Sofia, Marchesi, Francesco, Motta, Marina, Nizzoli, Maria Elena, Offidani, Massimo, Orsucci, Lorella, Spolzino, Angelica, Stelitano, Caterina, Storti, Sergio, Tedeschi, Alessandra, Trentin, Livio, Varettoni, Marzia, Visentin, Andrea, Volpetti, Stefano, Falini, Brunangelo, Pulsoni, Alessandro, Tiacci, Enrico, Zinzani, Pier Luigi, Pagano, Livio |
| Zdroj: |
Blood; November 2020, Vol. 136 Issue: 1, Number 1 Supplement 1 p32-33, 2p |
| Abstrakt: |
Hairy cell leukemia (HCL) is a rare lymphoproliferative disease with specific morphologic and molecular features and excellent prognosis. Although high rate of complete response (CR) has been reported after treatment with purine analogs, expecially cladribine (2CDA), relapse may occur during follow-up. The aim of the study is to review the efficacy, safety, long term remission rate and overall survival (OS) in those patients (pts) that received 2CDA as first line treatment. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
